U.S. Healthcare Spending Surges: Per-Person Costs Rise 9.1% in 2024—What’s Driving the Explosion?
May 18, 2026
American households and businesses are facing a growing financial burden as U.S. Healthcare spending reached a record $5.3 trillion in 2024, according to the latest CMS National Health Expenditure (NHE) Fact Sheet. Per-person spending on critical services—hospitals, prescription drugs, and long-term care—rose 9.1% from 2023 to 2024, nearly doubling the overall healthcare inflation rate of 7.2%.
This surge isn’t just a statistical blip. It reflects deeper systemic pressures: rising drug prices, increased utilization of specialty treatments, provider pricing power, and regulatory challenges. For employers, these costs are squeezing benefit budgets; for patients, out-of-pocket expenses are climbing faster than wages. And with projections showing healthcare spending could hit $5.6 trillion by 2025, the question isn’t whether costs will keep rising—it’s how quickly.
What’s Fueling the 9.1% Surge in Per-Person Healthcare Costs?
1. Hospital Services: The Biggest Cost Driver
Hospital expenditures grew 8.9% in 2024, accounting for $1.63 trillion—or nearly one-third of total U.S. Healthcare spending, per CMS data. While this growth slowed slightly from the 10.6% spike in 2023, it remains a primary driver of overall inflation.
Why the rise?
- Labor shortages: Hospitals continue to struggle with nurse and physician shortages, driving up wages and operational costs.
- Advanced treatments: Increased adoption of high-cost therapies (e.g., CAR-T cell treatments for cancer, advanced cardiac procedures) is pushing prices higher.
- Provider consolidation: Mergers and acquisitions among healthcare systems have reduced competition, allowing providers to command higher reimbursement rates.
2. Prescription Drugs: Specialty Medications Lead the Charge
Spending on prescription drugs increased 7.9% in 2024, totaling $467 billion. While this growth decelerated from the 10.8% jump in 2023, it remains a critical pain point for both insurers and patients.
Key contributors:
- GLP-1 drugs (e.g., Ozempic, Wegovy):** Their use for weight loss and diabetes has surged, with list prices exceeding $1,000 per month for some therapies.
- Cancer treatments:** Novel immunotherapies and gene-editing drugs (e.g., CRISPR-based therapies) carry price tags in the $200,000–$1 million range per patient.
- Pharma pricing power:** Drugmakers have faced limited price controls, allowing for steady annual increases.
3. Long-Term Care: An Overlooked but Growing Expense
While exact 2024 figures for long-term care (LTC) aren’t yet published in the NHE Fact Sheet, historical trends and employer reports indicate double-digit growth in this category. Factors include:
- Aging population:** The U.S. 65+ demographic is projected to grow 22% by 2033, increasing demand for nursing homes and home health services.
- Post-pandemic recovery:** Delayed care during COVID-19 has led to a backlog of patients requiring extended rehabilitation and chronic care.
- Workforce shortages:** LTC facilities report critical shortages of nurses and aides, driving up labor costs.
Who’s Footing the Bill? The Shifting Burden of Healthcare Costs
The CMS data reveals a fundamental shift in who pays for healthcare, with households and businesses shouldering an increasing share of the burden:
| Spending Category | 2024 Total ($ billion) | Growth Rate (2023–2024) | % of Total NHE |
|---|---|---|---|
| Private Health Insurance (including employer plans) | $1,644.6 | 8.8% | 31% |
| Out-of-Pocket | $556.6 | 5.9% | 11% |
| Medicare | $1,118.0 | 7.8% | 21% |
| Medicaid | $931.7 | 6.6% | 18% |
| Hospitals | $1,634.7 | 8.9% | 31% |
Source: CMS NHE Fact Sheet 2024
Key takeaways:
- Employers are the largest single funder of U.S. Healthcare, with private insurance spending hitting $1.64 trillion—up 8.8% in one year.
- Out-of-pocket costs are rising faster than wages, with Americans spending $556.6 billion directly on care, a 5.9% increase.
- Federal and state governments cover nearly half of all healthcare spending, but Medicaid enrollment declines threaten long-term sustainability.
Looking Ahead: Will Healthcare Spending Keep Climbing?
CMS projects that average annual healthcare spending growth will remain at 5.8% through 2033, outpacing GDP growth (projected at 4.3%). By 2033, healthcare could account for 20.3% of GDP—up from 18% in 2024.
What’s on the horizon?
- Continued drug price pressures: New biologics and gene therapies will drive costs, though biosimilars may offer some relief.
- Employer cost-shifting: More companies are adopting high-deductible plans or reference pricing to control expenses.
- Policy interventions: Potential reforms (e.g., Medicare price negotiation, surprise billing rules) could curb growth—but may also limit access.
- AI and telehealth: While these tools may reduce costs in some areas, they could also drive up demand for digital diagnostics and remote monitoring.
FAQ: Your Questions About Rising Healthcare Costs
1. Why are hospital costs rising faster than other healthcare expenses?
Hospitals face higher labor costs, supply chain disruptions, and increased demand for complex procedures. Consolidation among healthcare systems has reduced price competition, allowing hospitals to raise rates.
2. How are employers responding to soaring healthcare costs?
Employers are adopting strategies like:
- Negotiating harder with insurers and pharma.
- Shifting more costs to employees (e.g., higher deductibles).
- Investing in wellness programs to reduce long-term claims.
- Exploring alternative benefit designs (e.g., reference-based pricing).
3. Are prescription drug prices finally coming down?
Some relief is on the horizon:
- The Inflation Reduction Act (2022) allows Medicare to negotiate drug prices for 10 high-cost therapies starting in 2026.
- Biosimilars (generic versions of biologics) are reducing costs for some drugs (e.g., Humira).
- However, specialty drugs (e.g., GLP-1s, gene therapies) will continue driving price increases due to their high R&D costs.
4. How can individuals protect themselves from rising out-of-pocket costs?
Consider these steps:
- Shop for high-deductible plans if you’re healthy and can afford the upfront costs.
- Use FSA/HSA accounts to set aside pre-tax dollars for medical expenses.
- Negotiate medical bills—many providers offer discounts for cash payments.
- Explore telehealth for routine care to avoid emergency room surcharges.
The Bottom Line: A Cost Crisis with No Easy Fixes
The 9.1% surge in per-person healthcare spending is more than a statistic—it’s a warning sign. Without meaningful reforms, costs will continue to outpace wages, straining households, businesses, and government budgets alike.
For policymakers: Addressing drug pricing, provider consolidation, and workforce shortages must be a priority.
For employers: Proactive cost management—through pharmacy oversight, benefit design, and employee education—will be key to sustainability.
For patients: Understanding your coverage, advocating for transparency, and exploring cost-saving strategies can mitigate financial risk.
One thing is clear: The U.S. Healthcare system is at a crossroads. The choices made today will determine whether costs spiral further—or whether innovation and reform can bend the curve downward.